Australia markets closed

    +42.20 (+0.52%)

    -0.0020 (-0.30%)
  • ASX 200

    +39.40 (+0.50%)
  • OIL

    +0.17 (+0.21%)
  • GOLD

    +13.90 (+0.58%)
  • Bitcoin AUD

    -1,063.29 (-1.04%)
  • CMC Crypto 200

    -5.46 (-0.39%)

Swedish Growth Companies With High Insider Ownership To Watch In June 2024

As the broader European markets face heightened uncertainty due to rising inflation and cautious central bank policies, Sweden's market dynamics offer a unique landscape for investors focusing on growth companies with high insider ownership. Such firms often demonstrate a strong alignment between shareholders' interests and management, which can be particularly appealing in turbulent times. In this context, understanding the intrinsic qualities that contribute to the resilience and potential of these companies becomes crucial. High insider ownership can signal confidence in the company’s prospects from those who know it best—its leaders.

Top 10 Growth Companies With High Insider Ownership In Sweden


Insider Ownership

Earnings Growth

CTT Systems (OM:CTT)



BioArctic (OM:BIOA B)



Sileon (OM:SILEON)



InCoax Networks (OM:INCOAX)






Calliditas Therapeutics (OM:CALTX)



edyoutec (NGM:EDYOU)



Egetis Therapeutics (OM:EGTX)



Yubico (OM:YUBICO)



SaveLend Group (OM:YIELD)



Click here to see the full list of 82 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.


We're going to check out a few of the best picks from our screener tool.


Simply Wall St Growth Rating: ★★★★☆☆

Overview: Medicover AB operates in the healthcare and diagnostic services sector, serving regions including Poland and Sweden, with a market capitalization of approximately SEK 29.81 billion.

Operations: The revenue for the company is primarily generated through Healthcare Services at €1.26 billion and Diagnostic Services at €585.20 million.

Insider Ownership: 11.1%

Medicover, a Swedish growth company with significant insider ownership, has demonstrated robust earnings growth of 1492.9% over the past year and is expected to continue this trend with forecasts showing a 38.2% annual increase. Despite challenges in covering interest payments with earnings and large one-off items impacting financial results, Medicover trades at 51% below estimated fair value. Recent corporate guidance anticipates organic revenue exceeding €2.2 billion by year-end 2025, highlighting its potential amidst a competitive market landscape where it outpaces average Swedish market growth rates in both revenue and earnings.

OM:MCOV B Ownership Breakdown as at Jun 2024
OM:MCOV B Ownership Breakdown as at Jun 2024


Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pandox AB is a hotel property company that specializes in owning, operating, and leasing hotel properties, with a market capitalization of approximately SEK 34.86 billion.

Operations: The company generates its revenue primarily through two segments: own operation, which brings in SEK 3.24 billion, and rental agreements, contributing SEK 3.76 billion.

Insider Ownership: 12.3%

Pandox, a Swedish growth company, has shown a substantial earnings forecast with an expected annual increase of 46.3%, outpacing the Swedish market's 14.6%. Despite this, its dividend coverage is weak due to earnings not sufficiently covering interest payments and dividends. Recent financials reveal significant improvement with SEK 447 million in net income for Q1 2024, reversing a prior loss. However, profit margins have decreased from last year's high of 49.2% to just 1.1%.

OM:PNDX B Ownership Breakdown as at Jun 2024
OM:PNDX B Ownership Breakdown as at Jun 2024


Simply Wall St Growth Rating: ★★★★☆☆

Overview: Wallenstam AB (publ) is a property company based in Sweden, with a market capitalization of approximately SEK 34.92 billion.

Operations: The company generates revenue primarily from its operations in Gothenburg and Stockholm, with SEK 1.89 billion and SEK 920 million respectively.

Insider Ownership: 35%

Wallenstam AB, a Swedish growth company with high insider ownership, has shown mixed financial dynamics. While its revenue growth is modest at 3% annually, slightly outpacing the Swedish market forecast of 2.1%, its earnings are expected to surge by 53.73% per year. Recent substantial insider buying suggests confidence among Wallenstam's key stakeholders. However, the company's return on equity is projected to remain low at 4.6%. Additionally, recent financial results indicate a significant increase in net income to SEK 333 million in Q1 2024 from SEK 48 million a year prior, reflecting operational improvements and effective capital management through strategic initiatives like green bond issuances for sustainability projects.

OM:WALL B Earnings and Revenue Growth as at Jun 2024
OM:WALL B Earnings and Revenue Growth as at Jun 2024

Seize The Opportunity

Ready To Venture Into Other Investment Styles?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include OM:MCOV B OM:PNDX B and OM:WALL B.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email